Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Iran Produces 1st Anti-Cancer Nano Drug

Abstract:
Iranian scientists have developed the country's first anti-cancer drug using nanotechnology, an official announced.

Iran Produces 1st Anti-Cancer Nano Drug

Tehran, Iran | Posted on March 16th, 2014

"The first anti-cancer medicine was produced in Iran," Head of the Public Relations of the Presidential Office's Technological Cooperation Department Amir Khanian said in January.

He also said that the Iranian scientists have produced 18 biotech drugs and are carrying out research on another 29 biotech medicines.

Iran has taken wide strides in science and technology, particularly in medical and medicinal fields, in recent years.

The country has already mass-produced Doxorubicin - a non-carcinogenic drug - used in lung and breast cancer cases and made based on nano-liposomes technique. The drug with higher efficiency needs lower times for use and naturally lessens side effects, including vascular and heart complications.

Iran has also produced two other non-carcinogenic medicines Paclitaxel for breast and ovarian cancer and oxaliplatin for colon cancer.

In September, Iranian researchers from Lorestan University succeeded in designing a new type of drug delivery system for anti-cancer drugs by using linear dendritic polymers and iron nanoparticles.

Hybrid nanocomposites were used in this drug delivery system. Carbon nanotubes were also used in the system to make possible the quick passage through cellular walls.

Among the significant characteristic of the research was hybridization of a series of nanomaterials in a system to use all their properties in the elimination of cancerous cells.

Iran is among the very few countries which have developed a remedy for the most fearsome disease in the human community, known as AIDS. In 2007, Iranian scientists found a safe and effective cure for the dreaded virus, AIDS. This medicine made up of herbal and chemical components works to build immunity and enhance the quality of life of both AIDS and HIV-positive patients with no proven side effects.

Five years later, Iran helped Mali control and contain HIV infection across the African nation. A senior official of Iran's Red Crescent Society announced in August 2012 that HIV-infected patients in Mali had shown positive reactions to the Iran-made AIDS curing drug, Imod, in the course of their treatment.

"We have been witnessing highly positive results of Iran-made Imod drug on AIDS patients in Mali during the last two years," Deputy of RCS for Health, Treatment and Rehabilitation Abdolreza Shahrezayee told FNA on August 31, 2012.

He underlined Iran's extended health and treatment services in Mali, and said HIV-positive patients were being cured by Imod in RCS's polyclinic.

####

For more information, please click here

Copyright © Fars News Agency

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Harris & Harris Group Notes Announcements by Its Portfolio Companies During the Third Quarter of 2016 September 30th, 2016

INVECAS to Enable ASIC Designs for Tomorrows Intelligent Systems on GLOBALFOUNDRIES' FDX Technology: INVECAS to Collaborate with GLOBALFOUNDRIES to Provide IP and End-to-End ASIC Design Services on 22FDX and 12FDX Technologies September 30th, 2016

How to power up graphene implants without frying cells: New analysis finds way to safely conduct heat from graphene to biological tissues September 30th, 2016

Innovation in Nanotechnology is Focus of Symposium: Annual event brings international experts to Northwestern Oct. 6 September 29th, 2016

Nanomedicine

Harris & Harris Group Notes Announcements by Its Portfolio Companies During the Third Quarter of 2016 September 30th, 2016

How to power up graphene implants without frying cells: New analysis finds way to safely conduct heat from graphene to biological tissues September 30th, 2016

Nanosensors could help determine tumors ability to remodel tissue: Measuring enzyme levels could help doctors select appropriate treatments September 29th, 2016

Fighting cancer with sticky nanoparticles September 27th, 2016

Discoveries

How to power up graphene implants without frying cells: New analysis finds way to safely conduct heat from graphene to biological tissues September 30th, 2016

Nanosensors could help determine tumors ability to remodel tissue: Measuring enzyme levels could help doctors select appropriate treatments September 29th, 2016

Fighting cancer with sticky nanoparticles September 27th, 2016

Gold nanoparticles conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2 mediated pathway in breast cancer September 27th, 2016

Announcements

Harris & Harris Group Notes Announcements by Its Portfolio Companies During the Third Quarter of 2016 September 30th, 2016

INVECAS to Enable ASIC Designs for Tomorrows Intelligent Systems on GLOBALFOUNDRIES' FDX Technology: INVECAS to Collaborate with GLOBALFOUNDRIES to Provide IP and End-to-End ASIC Design Services on 22FDX and 12FDX Technologies September 30th, 2016

How to power up graphene implants without frying cells: New analysis finds way to safely conduct heat from graphene to biological tissues September 30th, 2016

Innovation in Nanotechnology is Focus of Symposium: Annual event brings international experts to Northwestern Oct. 6 September 29th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic